Nu Skin Enterprises, Inc. Class A (NUS)

Nu Skin Enterprises reported its Q1 and Q2 2025 financial results. In Q1 2025, the company met its revenue guidance and exceeded earnings expectations due to improving business trends and effective expense management. In Q2 2025, Nu Skin exceeded EPS expectations and delivered revenue at the high end of its guidance, highlighting progress in its strategic priorities, including the upcoming launch of Prysm iO and expansion into India. The Q2 gross margin was 68.8%, with the core Nu Skin business at 77.5%. The sale of its Mavely business generated approximately $200 million in value. The stock price as of October 20, 2025, was $10.80 per share, a 75.32% increase from October 21, 2024.

Nu Skin Enterprises, Inc. experiences demand seasonality for its products and services. A "NUS Seasonality" tool displays mean and median monthly returns to identify seasonal patterns, suggesting fluctuations in demand or stock performance throughout the year. The company engages in innovation and product launches to align with evolving beauty and wellness trends, which can influence demand.

Nu Skin Enterprises, Inc. is a global direct-selling company that develops and distributes beauty, personal care products, and nutritional supplements. Founded in 1984, it operates within the health, wellness, and beauty industries, utilizing a network of independent distributors to market its products directly to consumers. The company emphasizes scientific innovation and product efficacy, collaborating with research institutions. Major product brands include Nu Skin, Pharmanex, and ageLOC, featuring products like ageLOC LumiSpa, Nutricentials, LifePak, ageLOC TR90, and Beauty Focus Collagen+.

Nu Skin has a significant international market presence, distributing its products in approximately 50 markets worldwide. It operates across the Americas, Europe, Africa, and Asia-Pacific, segmented into regions like Mainland China, South Korea, Southeast Asia/Pacific, Japan, Hong Kong/Taiwan, and Europe, Middle East, and Africa. Nu Skin has manufacturing facilities in the United States and three in China, including a new facility in Fenshin.

Nu Skin's brand reputation is associated with its focus on scientific research and development in beauty and wellness, particularly in anti-aging. The company highlights its antioxidant database and commitment to sustainability, including transitioning to sustainable packaging by 2030. The Nu Skin Force for Good Foundation contributes to its reputation through efforts to improve children's health, education, and economic circumstances. However, as an MLM company, Nu Skin faces scrutiny and potential challenges to its business model, which may affect its reputation.

Institutional investors hold over 50% of Nu Skin Enterprises, Inc. shares, indicating their trading actions can influence the stock price. The top 18 shareholders collectively control 51% of the company's ownership. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., and D. E. Shaw & Co., Inc. Individual investors hold a 23% stake, and insiders own approximately US$8.1 million worth of the company's stock.